HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michel Koenig Selected Research

autosomal recessive 1 Spinocerebellar ataxia

12/2020Autosomal Recessive Cerebellar Ataxias With Elevated Alpha-Fetoprotein: Uncommon Diseases, Common Biomarker.
1/2018Clinical, Biomarker, and Molecular Delineations and Genotype-Phenotype Correlations of Ataxia With Oculomotor Apraxia Type 1.
1/2013Progressive cerebellar atrophy: hereditary ataxias and disorders with spinocerebellar degeneration.
7/2008Clinical and molecular findings of ataxia with oculomotor apraxia type 2 in 4 families.
3/2004Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michel Koenig Research Topics

Disease

14Ataxia (Dyssynergia)
05/2021 - 09/2003
11Cerebellar Ataxia (Dysmetria)
01/2021 - 03/2008
8Friedreich Ataxia (Friedreich's Ataxia)
05/2016 - 06/2002
6Neurodegenerative Diseases (Neurodegenerative Disease)
05/2016 - 06/2002
5autosomal recessive 1 Spinocerebellar ataxia
12/2020 - 03/2004
4Shock
09/2021 - 07/2006
4Ataxia Telangiectasia (Louis Bar Syndrome)
12/2020 - 01/2005
4Atrophy
01/2013 - 12/2003
3Muscular Diseases (Myopathy)
01/2021 - 01/2018
3Apraxias (Dyspraxia)
01/2018 - 03/2004
3Cardiomyopathies (Cardiomyopathy)
02/2005 - 01/2003
2Cystic Fibrosis (Mucoviscidosis)
01/2021 - 01/2020
2Fibrosis (Cirrhosis)
01/2020 - 01/2003
2Disease Progression
01/2020 - 06/2002
2Seizures (Absence Seizure)
01/2020 - 01/2019
2Epilepsy (Aura)
01/2019 - 08/2010
2Movement Disorders (Movement Disorder)
10/2018 - 10/2013
2Spinocerebellar Degenerations (Marinesco Sjogren Syndrome)
01/2018 - 01/2013
2Intellectual Disability (Idiocy)
02/2014 - 08/2010
2Coenzyme Q10 Deficiency
10/2013 - 03/2008
2Oculomotor Nerve Diseases (Oculomotor Nerve Palsy)
03/2004 - 12/2003
1Neurodevelopmental Disorders
01/2021
1Medulloblastoma
01/2021
1Nasal Polyps (Nasal Polyp)
01/2021
1Optic Nerve Diseases (Optic Neuropathy)
01/2021
1Nemaline Myopathies (Nemaline Myopathy)
01/2021
1Mitochondrial Diseases (Mitochondrial Disease)
01/2021
1Minicore Myopathy with External Ophthalmoplegia
01/2020
1Headache (Headaches)
01/2020
1Neurologic Manifestations (Neurological Manifestations)
01/2020
1Brain Diseases (Brain Disorder)
01/2019
1Hypoalbuminemia
01/2018
1Muscular Dystrophies (Muscular Dystrophy)
01/2018
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2017
1Spastic ataxia Charlevoix-Saguenay type
12/2015
1recessive Spastic paraplegia type 5A
03/2015
1Chromosomal Instability (Chromosome Stability)
09/2014
1Tonic-Clonic Epilepsy (Epilepsy, Tonic Clonic)
02/2014
1Karak Syndrome
01/2013
1Ataxia Telangiectasia Like Disorder
01/2013
1Neuroaxonal Dystrophies (Neuroaxonal Dystrophy, Late Infantile)
01/2013
1Pain (Aches)
09/2010
1Long Term Adverse Effects
09/2010
1Inflammation (Inflammations)
09/2010
1Inborn Genetic Diseases (Disease, Hereditary)
08/2009
1Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
04/2009
1Tremor (Tremors)
01/2009
1Parkinsonian Disorders (Parkinsonism)
01/2009
1Peripheral Nervous System Diseases (PNS Diseases)
07/2008
1Iron Overload
02/2005

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
05/2021 - 04/2009
8IronIBA
12/2016 - 01/2003
6alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2021 - 03/2004
6FrataxinIBA
05/2016 - 06/2002
5Biomarkers (Surrogate Marker)IBA
01/2021 - 12/2015
4coenzyme Q10 (CoQ10)IBA
01/2020 - 03/2008
4DNA (Deoxyribonucleic Acid)IBA
10/2018 - 09/2003
4Mitochondrial Proteins (Mitochondrial Protein)IBA
08/2009 - 06/2002
3EnzymesIBA
01/2021 - 05/2004
3ConnectinIBA
11/2020 - 01/2018
3Pharmaceutical PreparationsIBA
01/2019 - 08/2009
2Riboflavin (Vitamin B2)FDA LinkGeneric
01/2021 - 01/2016
2Biological ProductsIBA
01/2021 - 12/2003
2Fetal Proteins (Fetoprotein)IBA
01/2018 - 09/2014
2Immunoglobulins (Immunoglobulin)IBA
09/2014 - 01/2005
2UbiquinoneIBA
10/2013 - 03/2008
2SulfurIBA
08/2009 - 07/2009
2AntioxidantsIBA
02/2005 - 05/2004
1LipidsIBA
01/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021
1Troponin T (Troponin T1)IBA
01/2021
1MicroRNAs (MicroRNA)IBA
01/2021
1Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
01/2020
1GadoliniumIBA
01/2020
1Messenger RNA (mRNA)IBA
01/2020
1Myosins (Myosin)IBA
01/2020
1Abatacept (Orencia)FDA Link
01/2020
1SolutionsIBA
10/2018
1nebulinIBA
01/2018
1Serum AlbuminIBA
01/2018
1DystrophinIBA
01/2017
1N-ethylcarbaminomethyl-L-isoleucine (A 145)IBA
07/2016
1Adenosine Triphosphate (ATP)IBA
05/2016
1Fatty Acids (Saturated Fatty Acids)IBA
03/2015
1A 19IBA
02/2014
1Vitamin EFDA LinkGeneric
01/2013
1Chloride Channels (Chloride Channel)IBA
12/2010
1CalciumIBA
12/2010
1EndocannabinoidsIBA
09/2010
1DiglyceridesIBA
08/2010
1Nuclear Proteins (Protein, Nuclear)IBA
08/2010
1Levodopa (L Dopa)FDA LinkGeneric
01/2009
1Phosphotransferases (Kinase)IBA
03/2008
1Lactic Acid (Lactate)FDA LinkGeneric
03/2008
1DiamondIBA
04/2007

Therapy/Procedure

4Lasers (Laser)
09/2021 - 07/2006
2Therapeutics
01/2021 - 10/2013
1Precision Medicine
01/2021
1Ligation
01/2019
1Aftercare (After-Treatment)
08/2010